The results of clinical correlation analysis showed that the M stage of osteosarcoma patients decreased with increasing GZMA expression (Figure 6D, p < 0.01), while osteosarcoma patients with high CASP5 expression were younger (Figure 6E, p < 0.01), and all results are shown in Table 1. This evidence concerns the gene GZMA and osteosarcoma.